புற தலையீடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from புற தலையீடு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In புற தலையீடு Today - Breaking & Trending Today
BD Announces Third Fiscal Quarter Results; Strong Base Growth Drives Better Performance In Quarter And Higher Guidance For Fiscal 2021 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Becton Dickinson and : BD Announces Third Fiscal Quarter Results; Strong Base Growth Drives Better Per… marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Becton, Dickinson and Company (BDX) Q3 2021 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
BD Announces Second Fiscal Quarter Results; Reaffirms Fiscal 2021 Guidance - Second fiscal quarter revenues of $4.9 billion grew 15.4% on a reported basis. On a currency-neutral basis, revenues increased 12.2%. - BD s COVID-19 testing sales were $480 million, including BD Veritor™ Plus System revenues of $290 million. - BD s core growth led by strong growth in Medication Delivery Solutions (up 10.4%), Pharmaceutical Systems (up 15.4%), and Biosciences (up 16.3%) on a reported basis. - Second fiscal quarter GAAP diluted earnings per share (EPS) increased 77.4% year-over-year to $0.94. - Adjusted EPS increased 25.1% year-over-year to $3.19. - BD is reaffirming its fiscal 2021 revenue growth and adjusted EPS guidance. News provided by Share this article ....
Share this article Share this article FRANKLIN LAKES, N.J., April 14, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Pristine™ Long-Term Hemodialysis Catheter, a new hemodialysis catheter with a unique side-hole free symmetric Y-Tip™ distal lumen design. The Pristine™ Catheter will be available in the U.S. in May 2021. The device was developed by Pristine Access Technologies, Ltd., a privately-owned company based in Israel, which was acquired by BD in July 2020 as part of the company s ongoing growth strategy focused on tuck-in acquisitions and R&D investments in improved treatments for chronic diseases. ....